BLIS Technologies Limited logo

Distribution partner appointed for Canadian Market

Operational Update3 August 2020BLTConsumer Staples

4 August 2020
Distribution partner appointed for Canadian Market

Blis Technologies Limited (NZX:BLT) has finalised an agreement with Purity Life Health Products LP

(Purity Life) for the distribution of BLIS branded products into the pharmacy and health store retail

channels in Canada.


Purity Life will be launching Canada-specific BLIS® branded products from the BLIS K12™ and BLIS

M18™ range. The launch will be supported through a comprehensive consumer and trade marketing

programme that coincides with the build up towards the busy winter season in Canada.


Blis CEO Brian Watson commented “This partnership is another important milestone in realising the

Company’s growth ambitions, with the Canadian market representing a key new market for Blis.

Working with Purity Life gives us access to the best health stores and pharmacies in Canada. They

have exceptional reach into the Canadian consumer health market and a proven track record of

establishing category leading brands in consumer health care.”


Mr Watson added “In Canada we have attractive regulatory approvals that allow significant health

claims for our product range. Over the last year we have worked with New Zealand Trade and

Enterprise on an extensive market validation program that has provided insight and confidence in

the market opportunity. Prior to lock down we were fortunate to have several of the team travel to

Canada and meet with our preferred partners to support our launch as well as presenting our

products to the trade with positive engagement.”


Purity Life is Canada’s leading distributor of natural health products. From dietary supplements,

vitamins and natural body care to natural health food products, Purity Life supplies high quality

products to over 7,000 stores across Canada.


Ends


For further information, please contact:


Brian Watson

CEO

+64 27 705 9133


About Blis Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation

with evidence-based research and the highest quality production controls enables the delivery of probiotic

solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and

gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More

information about Blis Technologies Ltd can be found at www.blis.co.nz.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PEB — Pacific Edge Limited: Pacific Edge Announces FY20 Results
    2020-05-28

    29 May 2020 4 In New Zealand, demand from public healthcare providers continues to grow and the focus is now on upselling additional tests to existing customers and gaining adoption from the remaining DHBs. Continuing progress is being made in Southeast Asia with clinical…”